À proposConditionsConfidentialitéContact
 
Actualisation
Pharmaceutical Industry: Past, Present and Future

Pharmaceutical Industry: Past, Present and Future

Oxford University
Date de sortie : 2010-02-04
© Oxford University
Pharmaceutical Industry: Past, Present and Future - QR Code
Libre0%
4 épisodes
Audio
Écouter sur Apple Podcasts
Libre0%
4 épisodes
Audio
Écouter sur Apple Podcasts
Date de sortie : 2010-02-04
© Oxford University
L’épisode le plus récent
Is there a healthy future for Big Pharma?

Is there a healthy future for Big Pharma?

Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors.
Durée : 47:27
Lecture
Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. The Pharmaceutical industry has been through a period of unprecedented growth in the last three decades, fuelled by the advances in biomedical science and an increasingly affluent Western Society. Looking forward, the picture is less rosy with reduced research and development productivity coupled with increasing pre-registration data demands from regulators and burgeoning costs. Taken together with major products losing patent protection and the need for health care costs to be kept under control, the current business model is under threat. Dr Patterson will review the background to the crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors.
Id. d’épisode : 1000410383554
GUID : http://rss.oucs.ox.ac.uk/tag:2010-02-04:164357:219:grte/pharma-audio
Date de publication : 4/2/2010 à 16:28:46

Description

Is there a contradiction between profit-making and medical needs? How important are emerging markets for the future of pharmaceutical companies? And what are the ethical boundaries in the relationship between medical practitioners and pharma companies? This series of four lectures brings together leading figures in the pharmaceutical industry, health and business to look at the challenges of reconciling medical ethics and business in the 21st century against a backdrop of scientific and clinical developments and the expectations of patients.
This series was originally delivered as the 2009 Green Templeton Lectures entitled "Addicted to Big Pharma? Reconciling business, medical and ethical needs".

Adresse du flux

http://mediapub.it.ox.ac.uk/feeds/129129/audio.xml

Apple Podcasts : Avis des utilisateurs

Pas d'entrée